Simcere Pharmaceutical Group (SCR) Misses Q2 EPS by 9c
Tweet Send to a Friend
Simcere Pharmaceutical Group (NYSE: SCR) reported Q2 EPS of $0.03 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
